Have multiple conditions? Click here

New Clinical Trials for Prostate Cancer

Prostate cancer clinical research to date has revealed that a healthy diet and exercise can potentially help prevent development of the disease. Genetics play a big part in determining if someone will develop prostate cancer so there is a lot more research to be done in this area. Patients and their doctors must review factors such as tumor size, growth and speed of growth when determining a plan of action for treating prostate cancer.
 
If you are a survivor of prostate cancer, or perhaps are currently considering undergoing treatment, you may qualify for a prostate cancer clinical trial. Please review the list of current tests and contact us if you are interested. Participation is always at no cost to you.
 

What is Prostate Cancer?

Prostate cancer is cancer of the prostate, a gland found in the male reproductive system that makes and stores sperm. Initial symptoms of prostate cancer may include pain, trouble with urinating, problems with sexual intercourse, or erectile dysfunction. However, in some cases there are no symptoms and the cancer goes undiagnosed and untreated. This is because prostate cancer is a slow growing cancer. Patients often seek treatment for other ailments before their prostate cancer even becomes evident to them. It mostly affects those over age 50 and can spread to other organs. Common causes include age and family history.
 

Prostate Cancer Treatments

When prostate cancer is detected its treatments can include surgery, radiation therapy, proton therapy, and external beam radiation therapy. There are also some patients who choose close monitoring as their main form of prostate cancer treatment. If they have no symptoms and the cancer is not spreading this can be an effective way of managing the disease. Hormone therapies are sometimes used successfully in delaying the growth of prostate cancer, but this is not a long-term solution for treating prostate cancer.

Have multiple conditions? Click here

Showing 1-100 of 3900
There are 3900 Prostate Cancer Clinical Trials
Name City State Zip
Prostate Cancer Clinical Trial Birmingham AL 35216
Prostate Cancer Clinical Trial Birmingham AL 35216
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH). Mobile AL 36608
Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases Mobile AL 36608
Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer Mobile AL 36604
Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer Mobile AL 36608
Study of Immunotherapy to Treat Advanced Prostate Cancer Mobile AL 36608
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement Mobile AL 36608
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Mobile AL 36608
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Mobile AL 36608
Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer Homewood AL 35209
A Study of Degarelix in Patients With Prostate Cancer Homewood AL
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma Birmingham AL 35233
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer Birmingham AL 35294
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer Birmingham AL 35294
Clinical Study of the Sonablate® 500 to Treat Localized (T1c/T2a) Prostate Cancer Birmingham AL 35209
Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer Birmingham AL 35209
A Study Evaluating the Clinical Benefit of Adding Custirsen to Docetaxel Retreatment/Prednisone as Second Line Therapy in Men With Castrate Resistant Prostate Cancer (CRPC) Birmingham AL 35216
Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate Cancer Birmingham AL
Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate Cancer Birmingham AL
A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer Birmingham AL
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Birmingham AL
Pomegranate Extract in Treating Patients With Rising Prostate-Specific Antigen Levels After Surgery or Radiation Therapy for Localized Prostate Cancer Alexander City AL 35010
A Study of Degarelix in Patients With Prostate Cancer Alexander City AL
Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Fairbanks AK 99701
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer Fairbanks AK 99701
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer Fairbanks AK 99701
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement Fairbanks AK 99701
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Fairbanks AK 99701
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Fairbanks AK 99701
Pomegranate Extract in Treating Patients With Rising Prostate-Specific Antigen Levels After Surgery or Radiation Therapy for Localized Prostate Cancer Anchorage AK 99508
Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer Anchorage AK 99508
Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer Anchorage AK 99508
Study of Immunotherapy to Treat Advanced Prostate Cancer Anchorage AK 99508
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Anchorage AK 99508
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer Anchorage AK 99508
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer Anchorage AK 99508
Study of TAK-700 in Combination With Docetaxel and Prednisone in Men With Metastatic Castration-Resistant Prostate Cancer Anchorage AK 99508
Study Comparing Orteronel Plus Prednisone in Patients With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Anchorage AK
Study Comparing Orteronel Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Anchorage AK
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer Anchorage AK
Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer Tuscon AZ 85712
Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Tucson AZ 85723
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma Tucson AZ 85723
Using the Internet to Collect Symptoms and the Ability to Carry Out Daily Activities From Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy Tucson AZ 85723
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer Tucson AZ 85723
Selenium in Treating Patients With Prostate Cancer Tucson AZ 85724
Gemzar, Cisp, Sunitinib Urothelial Ca Tucson AZ 85745
Telephone Counseling: Men With Prostate Cancer & Partners Tucson AZ 85721
Study of Immunotherapy to Treat Advanced Prostate Cancer Tucson AZ 85715
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement Tucson AZ 85723
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer Tucson AZ 85704
Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer Tucson AZ 85704
A Study Evaluating the Clinical Benefit of Adding Custirsen to Docetaxel Retreatment/Prednisone as Second Line Therapy in Men With Castrate Resistant Prostate Cancer (CRPC) Tucson AZ 85723
Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors Tucson AZ 85724
Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer Sedona AZ 86336
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer Scottsdale AZ 85259
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement Scottsdale AZ 85259
Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate Cancer Scottsdale AZ 85259
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer Scottsdale AZ 85258
Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate Cancer Scottsdale AZ
Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer Phoenix AZ 85013
Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases Phoenix AZ 85013
Health-Related Quality of Life in Gay Men With Localized Prostate Cancer Phoenix AZ 85069
PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma Phoenix AZ 85040
Chemoprevention of Prostate Cancer, HDAC Inhibition and DNA Methylation Phoenix AZ 85012
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer Phoenix AZ 85013
Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer Phoenix AZ 85012
A Study Evaluating the Clinical Benefit of Adding Custirsen to Docetaxel Retreatment/Prednisone as Second Line Therapy in Men With Castrate Resistant Prostate Cancer (CRPC) Phoenix AZ 85054
Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy Peoria AZ 85381
Study Comparing Orteronel Plus Prednisone in Patients With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Peoria AZ
A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer Peoria AZ
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Peoria AZ
Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer Mesa AZ 85202
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer Mesa AZ 85202
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma No. Little Rock AR 72114
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer Little Rock AR 72205
Performance Evaluation of the AMS CONTINUUMâ„¢ Device Little Rock AR 72211
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Little Rock AR 72205
Study Comparing Orteronel Plus Prednisone in Patients With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Little Rock AR
Study Comparing Orteronel Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Little Rock AR
Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Ft. Smith AR 72903
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer Ft. Smith AR 72903
A Rollover Protocol For Patients Who Received CP-675,206 In Other Protocols Fayetteville AR 72703
Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer Fayetteville AR 72703
Study of Immunotherapy to Treat Advanced Prostate Cancer Fayetteville AR 72703
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck Fayetteville AR 72703
Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Whittier CA 90602
Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer Walnut Creek CA 94596
Safety Study of Autologous Dendritic Cells Injected Into the Prostate After Cryoablation for Advanced Prostate Cancer Ventura CA 93003
Salvage Cryotherapy in Recurrent Prostate Cancer Ventura CA 93003
This is a Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate Cancer Ventura CA 93003
Imaging of Residual Tumor During Prostatectomy Ventura CA 93003
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH). Van Nuys CA 91405
Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer Vallejo CA 94589
Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer Vallejo CA 94589
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer Vallejo CA 94589
Salvage Cryotherapy in Recurrent Prostate Cancer Vallejo CA 94589
Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy Vallejo CA 94589
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer Vallejo CA 94589

Showing 1-100 of 3900
Alabama - Alaska - Arizona - Arkansas - California - Colorado - Connecticut - Delaware - Washington DC - Florida - Georgia - Hawaii - Idaho - Illinois - Indiana - Iowa - Kansas - Kentucky - Louisiana - Maine - Maryland - Massachusetts - Michigan - Minnesota - Mississippi - Missouri - Montana - Nebraska - Nevada - New Hampshire - New Jersey - New Mexico - New York - North Carolina - North Dakota - Ohio - Oklahoma - Oregon - Pennsylvania - Rhode Island - South Carolina - South Dakota - Tennessee - Texas - Utah - Vermont - Virginia - Washington - West Virginia - Wisconsin - Wyoming
For Sponsors: Promote Your Study | For Research Sites: Promote Your Site

Copyright 2012 Clinical Trials Institute, LLC | All Rights Reserved
Login
Forgot password?
Enter your email and we will resend your password
Register